HEADER OXIDOREDUCTASE 25-OCT-99 1D8R OBSLTE 20-JAN-04 1D8R 1VJ3 TITLE STRUCTURAL STUDIES ON BIO-ACTIVE COMPOUNDS. CRYSTAL TITLE 2 STRUCTURE AND MOLECULAR MODELING STUDIES ON THE TITLE 3 PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE COFACTOR TITLE 4 COMPLEX WITH TAB, A HIGHLY SELECTIVE ANTIFOLATE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (DIHYDROFOLATE REDUCTASE); COMPND 3 CHAIN: A; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PNEUMOCYSTIS CARINII; SOURCE 3 GENE: C-DNA P.CARINII DHFR; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 6 EXPRESSION_SYSTEM_PLASMID: PT7-7 KEYWDS TAB, NADPH, MOLECULAR MODELING EXPDTA X-RAY DIFFRACTION AUTHOR V.CODY,N.GALITSKY,D.RAK,J.R.LUFT,S.F.QUEENER,C.A.LAUGHTON, AUTHOR 2 F.G.MALCOLM REVDAT 2 20-JAN-04 1D8R 1 OBSLTE REVDAT 1 25-OCT-00 1D8R 0 JRNL AUTH V.CODY,D.CHAN,N.GALITSKY,D.RAK,J.R.LUFT,W.PANGBORN, JRNL AUTH 2 S.F.QUEENER,C.A.LAUGHTON,M.F.STEVENS JRNL TITL STRUCTURAL STUDIES ON BIOACTIVE COMPOUNDS. 30. JRNL TITL 2 CRYSTAL STRUCTURE AND MOLECULAR MODELING STUDIES JRNL TITL 3 ON THE PNEUMOCYSTIS CARINII DIHYDROFOLATE JRNL TITL 4 REDUCTASE COFACTOR COMPLEX WITH TAB, A HIGHLY JRNL TITL 5 SELECTIVE ANTIFOLATE. JRNL REF BIOCHEMISTRY V. 39 3556 2000 JRNL REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH V.CODY,N.GALITSKY,D.RAK,J.R.LUFT,W.PANGBORN, REMARK 1 AUTH 2 S.F.QUEENER REMARK 1 TITL LIGAND-INDUCED CONFORMATIONAL CHANGES IN THE REMARK 1 TITL 2 CRYSTAL STRUCTURES OF PNEUMOCYSTIS CARINII REMARK 1 TITL 3 DIHYDROFOLATE REDUCTASE COMPLEXES WITH FOLATE AND REMARK 1 TITL 4 NADP+ REMARK 1 REF BIOCHEMISTRY V. 38 4303 1999 REMARK 1 REFN ASTM BICHAW US ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.N.CHAMPNESS,A.ACHARI,S.P.BALLANTINE,P.K.BRYANT, REMARK 1 AUTH 2 C.J.DELVES,D.K.STAMMERS REMARK 1 TITL THE STRUCTURE OF PNEUMOCYSTIS CARINII REMARK 1 TITL 2 DIHYDROFOLATE REDUCTASE TO 1.9 A RESOLUTION REMARK 1 REF STRUCTURE (LONDON) V. 2 915 1994 REMARK 1 REFN ASTM STRUE6 UK ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROFFT REMARK 3 AUTHORS : KONNERT,HENDRICKSON,FINZEL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 10325 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 11328 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1678 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.020 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.065 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.081 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.016 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.228 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.229 ; 0.500 REMARK 3 MULTIPLE TORSION (A) : 0.313 ; 0.500 REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : 0.334 ; 0.500 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.400 ; 3.000 REMARK 3 STAGGERED (DEGREES) : 23.600; 15.000 REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.564 ; 1.750 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.378 ; 2.500 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.641 ; 1.750 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.426 ; 2.500 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1D8R COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-OCT-1999. REMARK 100 THE RCSB ID CODE IS RCSB009895. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-1998 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU 200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPH REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10325 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.18700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 UL OF PROTEIN, 3 UL OF MES/KCL REMARK 280 BUFFER, 7 UL OF 50%(W/V) PEG 2000 IN 50 MM MES, 100 MM KCL, REMARK 280 AND PLACING THE MIXTURE IN MICROCENTRIFUGE TUBES FOR REMARK 280 EQUILIBRATION ON A THERMAL GRADIENT APPARATUS. , PH 6.0, A REMARK 280 NOVEL THERMAL GRADIENT TECHNIQUE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.56850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 C1' TAB 300 C1' TAB 301 0.00 REMARK 500 C2' TAB 300 C2' TAB 301 0.00 REMARK 500 C3' TAB 300 C3' TAB 301 0.00 REMARK 500 C4' TAB 300 C4' TAB 301 0.00 REMARK 500 C5' TAB 300 C5' TAB 301 0.00 REMARK 500 C6' TAB 300 C6' TAB 301 0.00 REMARK 500 CL8 TAB 300 CL8 TAB 301 0.00 REMARK 500 N8' TAB 300 N8' TAB 301 0.00 REMARK 500 C9' TAB 300 C9' TAB 301 0.00 REMARK 500 C10 TAB 300 C10 TAB 301 0.00 REMARK 500 C11 TAB 300 C11 TAB 301 0.00 REMARK 500 N17 TAB 300 N17 TAB 301 0.00 REMARK 500 C14 TAB 300 C14 TAB 301 0.00 REMARK 500 N22 TAB 300 N22 TAB 301 0.00 REMARK 500 N15 TAB 300 N15 TAB 301 0.00 REMARK 500 C15 TAB 300 C15 TAB 301 0.00 REMARK 500 N20 TAB 300 N20 TAB 301 0.00 REMARK 500 C20 TAB 300 C20 TAB 301 0.00 REMARK 500 N65 TAB 300 N65 TAB 301 0.02 REMARK 500 N18 TAB 300 N18 TAB 301 0.03 REMARK 500 C21 TAB 300 C19 TAB 301 0.29 REMARK 500 C31 TAB 300 C25 TAB 301 0.47 REMARK 500 O26 TAB 300 C30 TAB 301 0.54 REMARK 500 C28 TAB 300 O23 TAB 301 0.57 REMARK 500 C19 TAB 300 C21 TAB 301 0.64 REMARK 500 O23 TAB 300 C28 TAB 301 0.76 REMARK 500 C27 TAB 300 C22 TAB 301 0.76 REMARK 500 C22 TAB 300 C27 TAB 301 0.84 REMARK 500 C32 TAB 300 C24 TAB 301 0.96 REMARK 500 O23 TAB 300 C27 TAB 301 1.00 REMARK 500 C28 TAB 300 C22 TAB 301 1.05 REMARK 500 C24 TAB 300 C30 TAB 301 1.07 REMARK 500 C27 TAB 300 C21 TAB 301 1.08 REMARK 500 C24 TAB 300 C31 TAB 301 1.20 REMARK 500 C30 TAB 300 C25 TAB 301 1.26 REMARK 500 O26 TAB 300 C29 TAB 301 1.31 REMARK 500 C1' TAB 300 N8' TAB 301 1.32 REMARK 500 N8' TAB 300 C1' TAB 301 1.32 REMARK 500 N15 TAB 300 C15 TAB 301 1.34 REMARK 500 C15 TAB 300 N15 TAB 301 1.34 REMARK 500 N8' TAB 300 N65 TAB 301 1.35 REMARK 500 C10 TAB 300 N17 TAB 301 1.35 REMARK 500 N17 TAB 300 C10 TAB 301 1.35 REMARK 500 C14 TAB 300 N15 TAB 301 1.35 REMARK 500 N15 TAB 300 C14 TAB 301 1.35 REMARK 500 N65 TAB 300 N8' TAB 301 1.35 REMARK 500 C4' TAB 300 C5' TAB 301 1.37 REMARK 500 C5' TAB 300 C4' TAB 301 1.37 REMARK 500 N17 TAB 300 C14 TAB 301 1.37 REMARK 500 C14 TAB 300 N17 TAB 301 1.37 REMARK 500 C14 TAB 300 N22 TAB 301 1.37 REMARK 500 N22 TAB 300 C14 TAB 301 1.37 REMARK 500 C15 TAB 300 N20 TAB 301 1.37 REMARK 500 N20 TAB 300 C15 TAB 301 1.37 REMARK 500 C1' TAB 300 C2' TAB 301 1.39 REMARK 500 C2' TAB 300 C3' TAB 301 1.39 REMARK 500 C2' TAB 300 C1' TAB 301 1.39 REMARK 500 C3' TAB 300 C2' TAB 301 1.39 REMARK 500 C5' TAB 300 C9' TAB 301 1.39 REMARK 500 C5' TAB 300 C6' TAB 301 1.39 REMARK 500 C6' TAB 300 C5' TAB 301 1.39 REMARK 500 C9' TAB 300 C15 TAB 301 1.39 REMARK 500 C9' TAB 300 C5' TAB 301 1.39 REMARK 500 C15 TAB 300 C9' TAB 301 1.39 REMARK 500 C25 TAB 300 C31 TAB 301 1.39 REMARK 500 C32 TAB 300 O23 TAB 301 1.39 REMARK 500 C1' TAB 300 C6' TAB 301 1.41 REMARK 500 C3' TAB 300 C4' TAB 301 1.41 REMARK 500 C4' TAB 300 C3' TAB 301 1.41 REMARK 500 C6' TAB 300 C1' TAB 301 1.41 REMARK 500 N18 TAB 300 N65 TAB 301 1.42 REMARK 500 N18 TAB 300 C21 TAB 301 1.42 REMARK 500 C21 TAB 300 N18 TAB 301 1.42 REMARK 500 O23 TAB 300 C32 TAB 301 1.42 REMARK 500 C9' TAB 300 C10 TAB 301 1.44 REMARK 500 C10 TAB 300 C9' TAB 301 1.44 REMARK 500 C21 TAB 300 C27 TAB 301 1.45 REMARK 500 N65 TAB 300 N18 TAB 301 1.45 REMARK 500 C19 TAB 300 N18 TAB 301 1.46 REMARK 500 C24 TAB 300 C29 TAB 301 1.46 REMARK 500 C22 TAB 300 C29 TAB 301 1.47 REMARK 500 N18 TAB 300 C19 TAB 301 1.48 REMARK 500 C10 TAB 300 C11 TAB 301 1.52 REMARK 500 C11 TAB 300 C10 TAB 301 1.52 REMARK 500 C11 TAB 300 C20 TAB 301 1.57 REMARK 500 C20 TAB 300 C11 TAB 301 1.57 REMARK 500 C31 TAB 300 C24 TAB 301 1.58 REMARK 500 C32 TAB 300 C25 TAB 301 1.62 REMARK 500 C27 TAB 300 O23 TAB 301 1.65 REMARK 500 C29 TAB 300 C22 TAB 301 1.65 REMARK 500 C24 TAB 300 C32 TAB 301 1.67 REMARK 500 O23 TAB 300 C29 TAB 301 1.69 REMARK 500 C28 TAB 300 C24 TAB 301 1.69 REMARK 500 C22 TAB 300 C19 TAB 301 1.72 REMARK 500 C2' TAB 300 CL8 TAB 301 1.73 REMARK 500 CL8 TAB 300 C2' TAB 301 1.73 REMARK 500 C22 TAB 300 C28 TAB 301 1.83 REMARK 500 O26 TAB 300 C31 TAB 301 1.83 REMARK 500 C32 TAB 300 C22 TAB 301 1.92 REMARK 500 C24 TAB 300 C27 TAB 301 1.93 REMARK 500 C25 TAB 300 C32 TAB 301 1.93 REMARK 500 C32 TAB 300 O26 TAB 301 1.96 REMARK 500 O23 TAB 300 C31 TAB 301 2.02 REMARK 500 C24 TAB 300 C28 TAB 301 2.02 REMARK 500 C28 TAB 300 C21 TAB 301 2.09 REMARK 500 C19 TAB 300 C22 TAB 301 2.10 REMARK 500 C25 TAB 300 C30 TAB 301 2.11 REMARK 500 O23 TAB 300 C30 TAB 301 2.14 REMARK 500 OD2 ASP A 162 O HOH 212 2.17 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 38 CD - NE - CZ ANGL. DEV. = 29.7 DEGREES REMARK 500 ARG A 204 CD - NE - CZ ANGL. DEV. = 55.4 DEGREES REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 252 DISTANCE = 5.26 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CD2 RELATED DB: PDB DBREF 1D8R A 2 206 UNP P16184 DYR_PNECA 2 206 SEQRES 1 A 205 ASN GLN GLN LYS SER LEU THR LEU ILE VAL ALA LEU THR SEQRES 2 A 205 THR SER TYR GLY ILE GLY ARG SER ASN SER LEU PRO TRP SEQRES 3 A 205 LYS LEU LYS LYS GLU ILE SER TYR PHE LYS ARG VAL THR SEQRES 4 A 205 SER PHE VAL PRO THR PHE ASP SER PHE GLU SER MET ASN SEQRES 5 A 205 VAL VAL LEU MET GLY ARG LYS THR TRP GLU SER ILE PRO SEQRES 6 A 205 LEU GLN PHE ARG PRO LEU LYS GLY ARG ILE ASN VAL VAL SEQRES 7 A 205 ILE THR ARG ASN GLU SER LEU ASP LEU GLY ASN GLY ILE SEQRES 8 A 205 HIS SER ALA LYS SER LEU ASP HIS ALA LEU GLU LEU LEU SEQRES 9 A 205 TYR ARG THR TYR GLY SER GLU SER SER VAL GLN ILE ASN SEQRES 10 A 205 ARG ILE PHE VAL ILE GLY GLY ALA GLN LEU TYR LYS ALA SEQRES 11 A 205 ALA MET ASP HIS PRO LYS LEU ASP ARG ILE MET ALA THR SEQRES 12 A 205 ILE ILE TYR LYS ASP ILE HIS CYS ASP VAL PHE PHE PRO SEQRES 13 A 205 LEU LYS PHE ARG ASP LYS GLU TRP SER SER VAL TRP LYS SEQRES 14 A 205 LYS GLU LYS HIS SER ASP LEU GLU SER TRP VAL GLY THR SEQRES 15 A 205 LYS VAL PRO HIS GLY LYS ILE ASN GLU ASP GLY PHE ASP SEQRES 16 A 205 TYR GLU PHE GLU MET TRP THR ARG ASP LEU FTNOTE 1 CIS PROLINE - PRO 71 OMEGA = 0.02 FTNOTE 2 CIS GLYCINE - GLY 125 OMEGA = 0.07 PEPTIDE BOND DEVIATES FTNOTE 2 SIGNIFICANTLY FROM TRANS CONFORMATION HET NDP 207 48 HET TAB 300 33 HET TAB 301 33 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM TAB ACETIC ACID N-[2-CHLORO-5-[6-ETHYL-2,4-DIAMINO- HETNAM 2 TAB PYRIMID-5-YL]-PHENYL]-[BENZYL-TRIAZEN-3-YL]ETHYL ESTER FORMUL 2 NDP C21 H30 N7 O17 P3 FORMUL 3 TAB 2(C23 H26 CL N7 O2) FORMUL 5 HOH *75(H2 O1) HELIX 1 1 LEU A 29 PHE A 42 1 14 HELIX 2 2 ARG A 59 ILE A 65 1 7 HELIX 3 3 PRO A 66 ARG A 70 5 5 HELIX 4 4 SER A 97 TYR A 109 1 13 HELIX 5 5 GLY A 125 ASP A 134 1 10 HELIX 6 6 ASP A 162 SER A 166 5 5 HELIX 7 7 LYS A 173 GLY A 182 1 10 SHEET 1 A 8 HIS A 93 ALA A 95 0 SHEET 2 A 8 ARG A 75 ILE A 80 1 O ASN A 77 N HIS A 93 SHEET 3 A 8 SER A 51 GLY A 58 1 O ASN A 53 N ILE A 76 SHEET 4 A 8 GLN A 116 VAL A 122 1 O GLN A 116 N MET A 52 SHEET 5 A 8 LEU A 7 THR A 14 1 O THR A 8 N VAL A 122 SHEET 6 A 8 LEU A 138 ILE A 146 1 N ASP A 139 O LEU A 7 SHEET 7 A 8 PHE A 195 THR A 203 -1 O GLU A 198 N ILE A 145 SHEET 8 A 8 LYS A 170 LYS A 171 -1 O LYS A 170 N THR A 203 SHEET 1 A1 8 HIS A 93 ALA A 95 0 SHEET 2 A1 8 ARG A 75 ILE A 80 1 O ASN A 77 N HIS A 93 SHEET 3 A1 8 SER A 51 GLY A 58 1 O ASN A 53 N ILE A 76 SHEET 4 A1 8 GLN A 116 VAL A 122 1 O GLN A 116 N MET A 52 SHEET 5 A1 8 LEU A 7 THR A 14 1 O THR A 8 N VAL A 122 SHEET 6 A1 8 LEU A 138 ILE A 146 1 N ASP A 139 O LEU A 7 SHEET 7 A1 8 PHE A 195 THR A 203 -1 O GLU A 198 N ILE A 145 SHEET 8 A1 8 ILE A 190 GLU A 192 -1 N ILE A 190 O TYR A 197 SHEET 1 B 2 GLY A 18 GLY A 20 0 SHEET 2 B 2 VAL A 154 PHE A 155 -1 O VAL A 154 N ILE A 19 CISPEP 1 ARG A 70 PRO A 71 0 0.02 CISPEP 2 GLY A 124 GLY A 125 0 0.07 CRYST1 37.481 43.137 61.288 90.00 94.74 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026680 0.000000 0.002212 0.00000 SCALE2 0.000000 0.023182 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016372 0.00000